Remote Buying of Aclaris Therapeutics Inc through IEX is under development on ETFS.com.
Notify Me when it is readyRemote Selling of Aclaris Therapeutics Inc through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down to $20.87 via ETF Daily News
United Therapeutics Co. (NASDAQ:UTHR) Director Christopher Causey Sells 5,000 Shares of Stock via ETF Daily News
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Down to $12.67 via ETF Daily News
Rani Therapeutics (NASDAQ:RANI) Shares Gap Down to $12.37 via ETF Daily News
Century Therapeutics (NASDAQ:IPSC) Shares Gap Down to $9.08 via ETF Daily News
United Therapeutics Co. (NASDAQ:UTHR) Holdings Cut by Ritholtz Wealth Management via ETF Daily News
Financial Comparison: Graybug Vision (NASDAQ:GRAY) and ProQR Therapeutics (NASDAQ:PRQR) via ETF Daily News
Axsome Therapeutics (NASDAQ:AXSM) Shares Gap Up to $24.46 via ETF Daily News
United Therapeutics (NASDAQ:UTHR) Hits New 1-Year High at $243.30 via ETF Daily News
Karuna Therapeutics (NASDAQ:KRTX) Price Target Raised to $190.00 at JMP Securities via ETF Daily News
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.
- Waiting for IEX trades to start ...